Recombinant Cynomolgus HVEM/TNFRSF14 Fc Chimera Protein

Datasheet / CoA / SDS
Product Details
  • Purity
    >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
  • Endotoxin Level
    <0.10 EU per 1 μg of the protein by the LAL method.
  • Activity
    Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey HVEM/TNFRSF14 Fc Chimera is coated at 2 µg/mL (100 μL/well), biotinylated recombinant mouse BTLA Fc Chimera binds with a typical ED50 of 150-750 ng/mL.
  • Source
    Human embryonic kidney cell, HEK293-derived cynomolgus monkey HVEM/TNFRSF14 protein
    Cynomolgus Monkey HVEM/TNFRSF14
    Accession # XP_005545061
    IEGRMD Human IgG1
    N-terminus C-terminus
  • Accession #
  • N-terminal Sequence
  • Structure / Form
    Disulfide-linked homodimer
  • Predicted Molecular Mass
    44 kDa
    56-63 kDa, reducing conditions
Product Datasheets

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Certificate of Analysis Lookup

Certificate of Analysis Request Form

To download a Certificate of Analysis, please enter the catalog and lot numbers in the search box below.

Note: Certificate of Analysis not available for kit components.

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 500 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Data Image
WhenRecombinant Cymomologus HVEM/TNFRSF14 Fc Chimera (Catalog # 9197-HV) is coated at2 μg/mL, Recombinant  Biotinylated Mouse BTLA  Fc Chimera binds with a typicalED50 of 150-750 ng/mL.
Background: HVEM/TNFRSF14
HVEM (herpesvirus entry mediator), also known as TNFRSF14 and CD270, is a type I membrane protein in the TNF receptor superfamily, and it can both promote and inhibit T cell activity (1). Mature cynomolgous HVEM consists of a 171 amino acid (aa) extracellular domain (ECD) with three cysteine-rich domains (CRD), a 24 aa transmembrane segment, and a 42 aa cytoplasmic tail with a TRAF interaction domain (2, 3). Within the ECD, cynomolgous HVEM shares 88%, 54%, and 54% aa sequence identity with human, mouse, and rat HVEM, respectively. HVEM is highly expressed on naïve CD4+ T cells, CD8+ T memory cells, regulatory T cells, dendritic cells, monocytes, and neutrophils (4-8). Its expression declines during effector T cell activation but is up-regulated during Treg activation (4, 5). HVEM functions as a receptor for BTLA, CD160, LIGHT/TNFSF14, and Lymphotoxin-a (4, 9-12). Ligation of HVEM by LIGHT triggers T cell, monocyte, and neutrophil activation (8, 10) and contributes to Th1 inflammation and cardiac allograft rejection (13, 14). In contrast, HVEM binding to CD160 or BTLA suppresses T cell and dendritic cell activation (4, 7, 9, 10) and dampens intestinal inflammation (15). HVEM enhances the development of CD8+ T cell memory and Treg function (5, 6). It is additionally expressed on intestinal epithelial cells, where its binding by intraepithelial lymphocyte (IEL) expressed CD160 promotes epitheilal integrity and host defense (16). The herpesvirus envelope glycoprotein gD, which binds HVEM to initiate membrane fusion, can antagonize both BTLA and LIGHT binding (2, 9, 11).
  • References:
    1. del Rio, M.L. et al. (2010) J. Leukoc. Biol. 87:223.
    2. Montgomery, R.I. et al. (1996) Cell 87:427.
    3. Hsu, H. et al. (1997) J. Biol. Chem. 272:13471.
    4. Sedy, J. R. et al. (2005) Nat. Immunol. 6:90.
    5. Tao, R. et al. (2008) J. Immunol. 180:6649.
    6. Steinberg, M.W. et al. (2013) PLoS One 8:e77992.
    7. de Trez, C. et al. (2008) J. Immunol. 180:238.
    8. Heo, S.K. et al. (2006) J. Leukoc. Biol. 79:330.
    9. Gonzalez, L.C. et al. (2005) Proc. Natl. Acad Sci. USA 102:1116.
    10. Cai, G. et al. (2008) Nat. Immunol. 9:176.
    11. Mauri, D.N. et al. (1998) Immunity 8:21.
    12. Harrop, J.A. et al. (1998) J. Biol. Chem. 273:27548.
    13. Wang, J. et al. (2005) J. Immunol. 174:8173.
    14. Ye, Q. et al. (2002) J. Exp. Med. 195:795.
    15. Steinberg, M.W. et al. (2008) J. Exp. Med. 205:1463.
    16. Shui, J.W. et al. (2012) Nature 488:222.
  • Long Name:
    Herpesvirus Entry Mediator
  • Entrez Gene IDs:
    8764 (Human); 230979 (Mouse); 102137807 (Cynomolgus Monkey)
  • Alternate Names:
    ATAR; CD270 antigen; CD270; CD40-like protein; Herpes virus entry mediator A; Herpesvirus entry mediator A; HveA; HVEM; HVEMTR2HVEAATAR; LIGHTR; TNFRSF14; tumor necrosis factor receptor superfamily member 14; tumor necrosis factor receptor superfamily, member 14 (herpesvirus entrymediator); Tumor necrosis factor receptor-like 2; tumor necrosis factor receptor-like gene2
Related Research Areas


No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Have you used Recombinant Cynomolgus HVEM/TNFRSF14 Fc Chimera Protein?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Order Details

Contact Us to Order


Customer Information

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

R&D Systems Guarantee